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• MDT approach
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• The CNS role in DSD
WHAT IS A DSD?
• Congenital conditions in which development of chromosomal, gonadal or anatomic 
sex is atypical
• True genital ambiguity
• 1 in 5000 / 1 in 4500 births
• Genital anomalies
• 1 in 300 births
What words do you associate with DSD?
REVISED NOMENCLATURE: CHICAGO CONSENSUS 2006 
CLASSIFICATION OF DSD
• Sex chromosome DSD (variable)
• Turner syndrome
• Klinefelter syndrome
• Mixed gonadal dysgenesis
• 46,XY DSD (under virilised genetic male)
• Disorders of testicular development
• Ovotesticular DSD
• Disorders of androgen synthesis / action
• CAIS
• Others
• Hypospadias
• 46,XX DSD (over virilised genetic female)
• Disorders of ovarian development
• Ovotesticular DSD
• Androgen excess
• CAH
ENDOCRINOLOGY IN SEX DEVELOPMENT
HORMONES INVOLVED IN SEX DEVELOPMENT
• Produced in the placenta, adrenal glands and developing gonads
• Androgens synthesized by the Leydig cells from 8 to 9 weeks are 
one of the key regulators
• Control Wolffian ducts and external genitalia development
• AMH (MIH) produced by the Sertoli cells
• Insulin like hormone 3 (INSL3) made by the Leydig cells
• Oestrogens from the foetal / maternal ovary
• Pathway for steroid hormone synthesis
• HCG
HCG
• Serum levels of foetal testosterone mirror HCG, suggesting that the placenta has an important role in
the early years of male sexual development
• Key masculinising effects during second half of gestation
• Growth of penis and scrotum, and testicular descent
• Probably regulated by foetal hypothalamus
• Babies with congenital hypopituitarism and anencephaly have micropenis, hypoplastic
scrotum and cryptorchidism
• Now see very premature infants with IUGR
• These boy babies are inadequately masculinised
• Consistent with inadequate placental HCG to stimulate testosterone production from the
foetal Leydig cells during a critical phase of sex development
EMBRYOLOGY REMINDER
FORMATION OF INTERNAL STRUCTURES
• Foetal ovaries
• Make small amounts of testosterone and AMH (anti Mullerian
hormone)
• Foetal testes
• Make lots of both hormones
• The presence or absence of these hormones influences the development 
of the internal sex ducts:
• Mullerian ducts
• Found in boy and girl foetuses, but disappear in boys when the 
testes make AMH (Mullerian Inhibiting Hormone)
• Forerunners of the uterus, cervix, fallopian tubes and upper 
portion of the vagina
• Wolffian ducts
• Found in all foetuses but disappear in girls as they have no 
testes to produce testosterone
• Forerunners of vas deferens, epididymides, prostate gland and 
seminal vesicles
GENITALIA DEVELOPMENT – 7-8 WEEKS
• 7-8 weeks
• Presence of XY chromosome
• Triggers activation of SRY gene
• Initiates development of a testis
• Primary sex chords develop into Sertoli
cells
• AMH
• Leads to regression of the Mullerian
duct
• Leydig cells produce testosterone
• Stimulate Wolffian duct to form 
epididymis, vas deferens and seminal 
vesicles
GENITALIA DEVELOPMENT
• External genitalia remains same until 8 
weeks
• Central genital tubercle
• Masculine – DHT
• Penis
• Female
• Only enlarges a small amount to 
form the clitoris
EXTERNAL GENITALIA DEVELOPMENT
• A baby who doesn’t make a byproduct of 
testosterone called dihydrotestosterone (DHT) 
will grow a vulva
• If a baby does make DHT, they will grow a 
penis and scrotum
• DHT is made in our bodies when an enzyme 
called 5⍺ reductase is available
• This changes T to DHT
EXTERNAL GENITAL DEVELOPMENT
A REMINDER OF THE REPRODUCTIVE 
SYSTEMS
THE MALE REPRODUCTIVE SYSTEM
TESTES
• Produce sperm cells
• Developed from germ cells in 
seminiferous tubules
• Secrete testosterone by interstitial / 
Leydig cells
LEYDIG CELLS
• Found adjacent to the 
seminiferous tubules in the 
testicle
• Produce testosterone in the 
presence of LH
• LH binds to receptors 
within the cell
EPIDIDYMIS
• Storage site of sperm cells
• Absorbs about 90% of the fluid 
secreted by the testis
• Sperm remain stored here for 40 –
60 days 
• Absorbed if not ejaculated 
prior to that time
THE FEMALE REPRODUCTIVE SYSTEM
THE OVARY
• Produce oocytes (oogenesis
• Most primary oocytes undergo a process of 
degeneration called atresia. Only 2 million remain 
at the time of birth, and by puberty, only 400,000 
remain
• Only one oocyte is ovulated each 28-day cycle
• Produce hormones:
• Oestrogen
• Progesterone
• Inhibin
• Androgens
• The release of an oocyte does not alternate between
the two ovaries and seems to be random
• After removal of an ovary, the remaining one produces
an egg every month
DIFFERENT DSD
• 46 XY DSD
• 46 XX DSD
• Sex chromosome DSD
CHROMOSOMES OVERVIEW
XX AND XY CHROMOSOMES
• XX – genotypic female
• XY – genotypic male
• Half of sperm cells carry the X chromosome, and half 
carry the Y chromosome
• The SRY gene present on the Y chromosome will act 
as a signal for the pathway for maleness
• Starts off virilisation
• Can also have a chromosomal arrangement that is 
contrary to phenotypic sex
• XX males
• XY females
• Abnormal number of sex chromosomes may be 
present
• DSD
46XY DSD - PRESENTATION
• Absence of secondary sexual characteristics in an adolescent boy
• Hypospadias
• Ambiguous genitalia at birth
• Primary amenorrhea in an adolescent child with a complete female phenotype
• Variation depends on 2 factors:
• Degree in disturbance of androgen production or action
• Point at which this disturbance occurs  during sex development
• Anatomic presentation can be classified by using clinical rating scales
CLINICAL RATING SCALES
• External Masculinisation Scale
• Score of < 7 is considered ambiguous
• Virilisation of XX individudals (Prader)
CLINICAL RATING SCALES
• Androgen Insensitivity (Quigley)
• Hypospadias classification
46XY- ANDROGEN INSENSITIVITY SYNDROME
• Complete absence of androgen action from the time of early foetal development  results in a child with a typical 
female external phenotype (CAIS)
• Partial action of androgens during foetal development causes hypospadias
• Micropenis can occur
• Cryptorchidism
• Mullerian structures may be present or absent
• If AMH not released, then internal structures may remain as female
• Must determine if present as will have a bearing on fertility if raised female
• Gonadal germ cell cancer risk
• Increased in testes with impaired development and presence of Y chromosome material
• PAIS and raised as male – strict cancer surveillance
• CAIS and raised as female – prophylactic gonadectomy

CAIS / PAIS
• PAIS
• Showing minimal virilisation of phallus 
and genital folds
• More virilised, where the genitalia show 
unfused labio-scrotal folds, but 
pigmentation and wrinkling more 
noticeable, with a larger phallus
• CAIS
• Showing normal female external 
genitalia, but visible gonads in the groin
46XY - PERSISTENT MULLERIAN DUCT SYNDROME 
• Mutations in the gene encoding AMH
• Lead to persistence of Mullerian duct organs in a 46XY individual
• Usually present
• Cryptorchidism
• Uterine remnants only apparent on examination, or later inguinal 
herniation
46XY GONADAL DYSGENESIS
• This occurs when there is disruption in the testicular developmental pathway toward mature Sertoli and Leydig
cells
• Usually leads to:
• Small testes with poor androgen-production capacity
• Presence of mullerian structures
• Elevated gonadotrophins from puberty
• Primary gonadal failure
• Inadequate early androgen production leading to bifid scrotum and severe                                                     
chordee of phallus                                                                                                
46XX PRESENTATION
• Ambiguous genitalia
• More than half of all infants born with AG are 46XX
• Due to in utero exposure of androgens 
• Source may be adrenal (CAH) or testicular
• Complex congenital malformations
• Cloacal extrophy, or bladder extrophy
• Gradual clitoris enlargements during childhood
• Non classical CAH
• Abnormal developments at puberty
• Primary amenorrhoea
• No breast or pubic hair development (46XX gonadal dysgenesis or steroid biosynthetic 
defects) OR
• Normal breast and pubic hair development (Mullerian duct agenesis)
• Normal breast development but little or no pubic hair (CAIS)
46XX CAH
• Baby will have been exposed to excess 
male hormone in-utero
• The genitalia will look like a boy’s:
• Labia will fuse to look like a scrotum
• Clitoris enlarges and looks like a penis
• Can sometimes be so severe, sex 
assignment is difficult
• Need karyotype
• Will still have normal internal 
structures
• Surgery may be needed to correct 
outer appearance
• CONTROVERSIAL
• Exposure to prenatal androgens and Prader 3 virilisation 
at birth
• Same baby at age 8 weeks at the time of genital 
reconstruction, showing some regression of virilisation 
after starting steroid treatment
• Another baby girl with a more 
severe form of 21OHD,
leading to more
severe virilisation 
(Prader IV)
46XX GONADAL DYSGENESIS
• Mutations in FSH receptor gene has been identified
• ‘Pure’ without features of TS
• Streak gonads are present due to germ cells not forming properly
• Mostly composed of fibrous tissue
• Characterised by primary amenorrhoea with or without 
secondary sexual characteristics
46XX MULLERIAN DUCT AGENESIS
• Vaginal agenesis usually associated with an absent uterus  and fallopian tubes but with 
normal ovarian development
• Mayer–Rokitansky–Küster–Hauser syndrome
46XX TESTICULAR DSD
• 1 in every 20,000 males with testes has a 46XX karyotype
• Translocation of SRY to the tip of one of the X chromosomes has occurred
• Phenotypical similarities between 46XX men and those with Klinefelter Syndrome
• 46XX men shorter         
•
SEX CHROMOSOME DSD
• 46XX Ovo-testicular DSD
• Klinefelter Syndrome
• Turner Syndrome 
• 45X / 46XY
46XX OVO-TESTICULAR DSD
• Specific type of gonadal dysgenesis
• Presence of ovarian follicles and seminiferous tubules in the gonads
• Distribution in the gonads vary
• 89% of ovotestes, ovarian and testicular elements are evenly distributed
• Testicular tissue undergoes atresia at a faster rate than ovarian tissue
• Phenotype varies
• Often testis on right and ovary on left
• Small number of women can become mothers
• Paternity never reported
• Gonad most likely to function will be the ovary
• Gonadal cancer risk in 46XX ovo-testicular DSD is low risk
• May be fertile oocytes
• Spermatogenesis absent
• Excise testicular component if it  can be identified    
• If not, leave till puberty and remove tissue that is producing the unwanted hormones
KLINEFELTER SYNDROME 47XXY
• Affects sexual development
• Testes don’t fully develop
• Oligospermic
• Lower levels of 
testosterone
• Taller than average
• Many men only discover 
this when they seek help 
for infertility
TURNER SYNDROME 
• Only affects girls
• Affects growth and sexual development
• Ovaries aren’t developed properly
• In TS the second sex chromosome is either:
• Completely absent (45,X) (Monosomy X)
• Partially absent
• Forms an isochromosome (isoXq), possessing a long arm duplication (q) 
and being devoid of a short arm (p)[
• In a ring formation (rX)[
• Is devoid of the homeobox gene, SHOX (short stature homeobox)
• Any of these variations of the second sex chromosome may occur with or 
without cell line mosaicism
• Missing the X in only some of the cells
• May have fewer symptoms 
• All except 1% of 45X foetuses are miscarried
45X/46XY DSD
• Right gonad has a reasonable testis which has 
descended into a hemi-scrotum
• Left side gonad was intra-abdominal streak 
gonad
• Vaginal cavity present
• Raised a boy, gonads left insitu
• Re-presented in adolescence with a tumour
arising from the streak gonad
• Wide range of phenotypes
• 95% - normal male
• SS and dysgenetic testes
• Female phenotype
• Features of TS (where karyotype has Y chromosome)
• Mixed gonadal dysgenesis
• Asymmetrical appearance
• 75% have a uterus
• SS in 84%
• GH therapy
• Abnormalities of urinary tract and CVS may be present
• Similiar to those of TS
DSD MDT TEAM 
Endocrinologist
Urologist
Psychologist
CNS
Gynaecologist Reproductive medicine
Biochemist Pathologist & Histopathologist
Imaging & 
Urodynamics
Local Paediatrician
+/- Surgeon / Urologist
+/- Midwives / Nurses
Clinical & 
Molecular 
genetics
General 
Practitioner & 
Social Work
Community and 
Religious Leaders Ethicist
MAKING THE DIAGNOSIS
(AHMED, 2011)

CLINICAL NURSE SPECIALIST ROLES
Clinical 
nurse 
specialist
Consultant
Educator
Researcher
Collaborator
Leader
Change 
Agent
Patient
advocate
Liaison
CNS ADVOCATE ROLE – AT DIAGNOSIS
• Ensure referring team has parents admission leaflet
• Liaising with the MDT
• From the referring team and also the team being referred 
to
• Is the baby well / hospitalised
• Are they requiring transport / nurse escort / will that nurse 
stay with patient
• Liaising with the ward
• Ensure GnRH, Synacthen and HCG in stock on ward if need 
be
• Liaising with the parents!
• Prepare information packs for parents
• DSD families leaflet
• Cortisol deficiency booklets
• CAH information
• CNS contact details
• How is the baby feeding
• Breast pump, bottles, quiet area available
• Bottle feeding – enough milk
• Ensure parents bring
• Phone chargers, nappies, wipes, books etc, lists of questions
• Maternity notes, child health care notes, referral letters
• Money for parking
• Can they speak English
• Arrange interpreter, prepare translated information 
CNS ADVOCATE ROLE - ONGOING
• Key liaison and support for family
• Involvement in support groups / support group days
• Be knowledgeable in specific condition and long term
implications
• Prepared for discussions on puberty and 
adolescence and beyond
• Liaise with adult DSD / gynaecology teams
• Patient and family empowerment
CONCLUSION..
• Brief overview of DSD conditions
• Many more complex variants
• Diagnosis
• Management
• Treatment
• Links with adrenal and gynaecology
•
Sleeping Hermaphroditus
